Advanced search
Publication Cover
Infection and Drug Resistance Volume 11, 2018 - Issue
Submit an article Journal homepage
87
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan

Yuan-Pin Hung1 Department of Internal Medicine, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan;3 Graduate Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan
,
Pei-Jane Tsai4 Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
,
Yuan-Ti Lee5 Institute of Medicine and School of Medicine, Chung Shan Medical University, Taichung, Taiwan;6 Division of Infectious Diseases, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
,
Hung-Jen Tang7 Department of Internal Medicine, Chi-Mei Hospital, Tainan, Taiwan
,
Hsiao-Ju Lin1 Department of Internal Medicine, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan;3 Graduate Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan
,
Hsiu-Chuan Liu1 Department of Internal Medicine, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan
,
Jen-Chieh Lee2 Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
,
Bo-Yang Tsai4 Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
,
Po-Ren Hsueh8 Departments of Laboratory Medicine and Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, TaiwanCorrespondence[email protected]
&
Wen-Chien Ko2 Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan;9 Center of Infection Control, National Cheng Kung University Hospital, Tainan, Taiwan;10 Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, TaiwanCorrespondence[email protected]
 show all
Pages 1197-1203 | Published online: 15 Aug 2018

References

  • Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med. 2006;145:758–764.
  • Kelly CP, LaMont JT. Clostridium difficile--more difficult than ever. N Engl J Med. 2008;359:1932–1940.
  • Hung YP, Lin HJ, Tsai BY, et al. Clostridium difficile ribotype 126 in southern Taiwan: a cluster of three symptomatic cases. Anaerobe. 2014;30:188–192.
  • Hung YP, Cia CT, Tsai BY, et al. The first case of severe Clostridium difficile ribotype 027 infection in Taiwan. J Infect. 2015;70:98–101.
  • Lai MJ, Chiueh TS, Huang ZY, Lin JC. The first Clostridium difficile ribotype 027 strain isolated in Taiwan. J Formos Med Assoc. 2016;115:210–212.
  • Liao TL, Lin CF, Chiou CS, Shen GH, Wang J. Clostridium difficile PCR ribotype 027 emerges in Taiwan. Jpn J Infect Dis. 2015;68:338–340.
  • Hung YP, Huang IH, Lin HJ, et al. Predominance of Clostridium difficile Ribotypes 017 and 078 among toxigenic clinical isolates in southern Taiwan. PLoS One. 2016;11:e0166159.
  • Tang C, Cui L, Xu Y, et al. The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis. Sci Rep. 2016;6:37865.
  • Liao CH, Ko WC, Lu JJ, Hsueh PR. Characterizations of clinical isolates of Clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in Taiwan. Antimicrob Agents Chemother. 2012;56:3943–3949.
  • Chia JH, Lai HC, Su LH, Kuo AJ, Wu TL. Molecular epidemiology of Clostridium difficile at a medical center in Taiwan: persistence of genetically clustering of A(-)B(+) isolates and increase of A(+)B(+) isolates. PLoS One. 2013;8:e75471.
  • Schmidt C, Loffler B, Ackermann G. Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile. Diagn Microbiol Infect Dis. 2007; 59:1–5.
  • Lin YC, Huang YT, Tsai PJ, et al. Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in taiwan. Antimicrob Agents Chemother. 2011;55:1701–1705.
  • Sheitoyan-Pesant C, Abou Chakra CN, Pepin J, Marcil-Heguy A, Nault V, Valiquette L. Clinical and healthcare burden of multiple recurrences of Clostridium difficile infection. Clin Infect Dis. 2016;62:574–580.
  • Persson S, Jensen JN, Olsen KE. Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and internal in-frame deletion of tcdC. J Clin Microbiol. 2011;49:4299–4300.
  • Clinical and Laboratory Standards Institute. 2015. Performance Standards for Antimicrobial Susceptibility Testing; 25th Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute.
  • European Committee on Antimicrobial Susceptibility Testing. 2016. Breakpoint tables for interpretation of MICs and zone diameters, version 6.0. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_6.0_Breakpoint_table.pdf. Accessed June 15, 2018.
  • Lee YC, Wang JT, Chen AC, Sheng WH, Chang SC, Chen YC. Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan. J Microbiol Immunol Infect. 2012;45:287–295.
  • Chung CH, Wu CJ, Lee HC, et al. Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis. J Microbiol Immunol Infect. 2010;43:119–125.
  • Hung YP, Lin HJ, Wu TC, et al. Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure. PLoS One. 2013;8:e69577.
  • Keessen EC, Hensgens MP, Spigaglia P, et al. Antimicrobial susceptibility profiles of human and piglet Clostridium difficile PCR-ribotype 078. Antimicrob Resist Infect Control. 2013;2:14.
  • Doernberg SB, Winston LG, Deck DH, Chambers HF. Does doxycycline protect against development of Clostridium difficile infection? Clin Infect Dis. 2012;55:615–620.
  • El-Herte RI, Baban TA, Kanj SS. Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature. Scand J Infect Dis. 2012;44:228–230.
  • Knight DR, Riley TV. Clostridium difficile clade 5 in Australia: antimicrobial susceptibility profiling of PCR ribotypes of human and animal origin. J Antimicrob Chemother. 2016;71:2213–2217.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.